Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grignani

Showing results (581-590 of 688) with videos related to

Pageof 69
Sort By:
Annals of Surgical Oncology|July 29, 2025
Correction: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Journal for Immunotherapy of Cancer|April 21, 2022
Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 studyNizar M Tannir, Daniel C Cho, Adi Diab, et al.
Annals of Surgical Oncology|August 31, 2025
ASO Visual Abstract: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PECOMA): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
British Journal of Cancer|August 30, 2017
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinibHeikki Joensuu, Jean-Yves Blay, Alessandro Comandone, et al.
Cancers|July 2, 2021
Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 StudySebastian Dorin Asaftei, Nadia Puma, Anna Paioli, et al.
JAMA Network Open|January 24, 2025
18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal TumorsMaria Concetta Nigro, Andrea Marchetti, Elena Rosa Fumagalli, et al.
Blood|January 13, 2006
Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHDFabrizio Carnevale-Schianca, Alessandro Cignetti, Antonio Capaldi, et al.
Future Oncology (London, England)|April 15, 2021
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcomaMrinal Gounder, Albiruni R Abdul Razak, Adrienne M Gilligan, et al.
Molecular Cancer|April 30, 2017
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical modelsYmera Pignochino, Federica Capozzi, Lorenzo D'Ambrosio, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2017
Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumourLorenzo D'Ambrosio, Erica Palesandro, Paola Boccone, et al.
Pageof 69

Showing results (581-590 of 688) with videos related to

Sort By:
Pageof 69
Annals of Surgical Oncology|July 29, 2025
Correction: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Journal for Immunotherapy of Cancer|April 21, 2022
Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 studyNizar M Tannir, Daniel C Cho, Adi Diab, et al.
Annals of Surgical Oncology|August 31, 2025
ASO Visual Abstract: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PECOMA): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
British Journal of Cancer|August 30, 2017
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinibHeikki Joensuu, Jean-Yves Blay, Alessandro Comandone, et al.
Cancers|July 2, 2021
Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 StudySebastian Dorin Asaftei, Nadia Puma, Anna Paioli, et al.
JAMA Network Open|January 24, 2025
18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal TumorsMaria Concetta Nigro, Andrea Marchetti, Elena Rosa Fumagalli, et al.
Blood|January 13, 2006
Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHDFabrizio Carnevale-Schianca, Alessandro Cignetti, Antonio Capaldi, et al.
Future Oncology (London, England)|April 15, 2021
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcomaMrinal Gounder, Albiruni R Abdul Razak, Adrienne M Gilligan, et al.
Molecular Cancer|April 30, 2017
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical modelsYmera Pignochino, Federica Capozzi, Lorenzo D'Ambrosio, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2017
Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumourLorenzo D'Ambrosio, Erica Palesandro, Paola Boccone, et al.
Pageof 69